Nyumbani › Scleroderma › Florida › Plantation
Majaribio ya kliniki ya Scleroderma katika Plantation, FL
Masomo 4 ya Scleroderma yanatafuta washiriki katika vituo vya Plantation na maeneo yake (ndani ya takriban maili 30). Fungua somo kuona nani anaweza kujiunga na jinsi ya kuwasiliana na timu ya utafiti.
Maandishi rasmi ya utafiti (Kiingereza)
Unavutia washiriki kwa utafiti hapa? Weka juu ya ukurasa huu — $99 kwa siku 30 →
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
InaajiriHatua 3
- Integral Rheumatology and Immunology Specialist, Plantation
A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis
InaajiriHatua 2
- IRIS Research and Development LLC, Plantation
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
InaajiriHatua 1/2
- Nkarta Investigational Site, Plantation
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
InaajiriHatua 2
- Artiva Investigational Site Plantation, Plantation
Majaribio ya Scleroderma katika miji mingine
- New York City, NYUtafiti 11
- Ann Arbor, MIUtafiti 10
- Chicago, ILUtafiti 10
- Houston, TXUtafiti 9
- Boston, MAUtafiti 7
- Durham, NCUtafiti 7
- Los Angeles, CAUtafiti 7
- New Orleans, LAUtafiti 6
- Baltimore, MDUtafiti 6
- Philadelphia, PAUtafiti 6
- Dallas, TXUtafiti 5
- Pittsburgh, PAUtafiti 5
Masomo mengine katika Plantation
- Saratani ya Mapafu Isiyo na Selu NdogoUtafiti 16
- Saratani ya MatitiUtafiti 14
- LupusUtafiti 7
- Saratani (aina zote)Utafiti 7
- Saratan ya MapafuUtafiti 7
- Arthritis ya RheumatoidUtafiti 6
- Saratani ya MetastasiUtafiti 6
- Kansari ya kolorektaliUtafiti 5
- Arthritis ya PsoriasisUtafiti 5
- Saratani ya ProstateUtafiti 5
- Kansari ya Seluli za Skwamu za Kichwa na ShingoUtafiti 4
- Multiple MyelomaUtafiti 4
Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.